ARCHIVES

FDA Clears Avastin-Interferon Combination In Renal Cancer; Interferon Role Undefined.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: Big Ten Cancer Research Consortium Names Executive Officer

May 30, 2014

Three Cooperative Groups To Combine Statistical Center Operations

July 2, 2010

Panel Resumes Deliberations

January 4, 1980

Brothers Of Prostate Cancer Patients At Risk Of Diagnosis

August 27, 2010

In Brief: Bruce Chabner, DC director, To Leave NCI Next Spring For Position At Mass General

October 28, 1994

Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months

September 27, 2013